For weight management in people without diabetes, NICE recommends considering specific GLP-1 agonists (semaglutide 2.4mg or liraglutide 3mg) only in specialist weight management services, for individuals with a BMI 35 kg/m (or 32.5 kg/m for people from South Asian, Chinese, other Asian, Black African, or African-Caribbean backgrounds) who have weight-related comorbidities
The answer is always individualized
His goal is to help patients build long-term wellness through practical habits, proper nutrition, and treatments that support the bodys natural ability to heal
In the PWA model, with overt metabolic and gonadal perturbations, chronic intervention with GLP1/E or the triagonist markedly reduced body weight, food intake, and circulating leptin levels (Fig